Skip to main content

Table 2 The sensitivity of the SELDI marker pattern in lung cancer patients with different stages and pathological types.

From: Application of serum SELDI proteomic patterns in diagnosis of lung cancer

Variables

n

Correct cases

Error cases

Sensitivity (%)

P value

Clinical stages

     

I/II

43

34

9

79.1

 

III/IV

41

39

2

95.1

<0.05

Pathological types

     

NSCLC

70

64

6

91.4

 

SCLC

14

9

5

64.3

<0.05

  1. NSCLC: non-small cell lung cancer; SCLC: small cell lung cancer.